Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesReuben Benjamin, Jackie Chappell, Oana Mirci‐Danicar et al.|The Lancet|2020Cited by 358
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCLMichael Northend, William Townsend, William Wilson et al.|Blood Advances|2022Cited by 44